FullSizeRender 28.jpg


FZata's mission is to make biologic therapies accessible to all patients.  Our technologies will 1) improve patient outcomes, 2) make biologics affordable and 3) replace the IV with a convenient oral capsule. Using our proprietary yeast delivery and multi-specific antibody platforms, we have developed a pipeline of bio-superiors to fight against GI-related infectious diseases, inflammation and metabolic diseases.


FZata is proud to have been selected as "2017 Maryland Incubator Company of the Year, the Best Life Sciences Company". The award recognizes achievements by companies in  Maryland business incubators. Saul Ewing, the Maryland Technology Development Corporation (TEDCO) and McGladrey established the Maryland Incubator Company of the Year Awards in 2001.